Successful intrauterine treatment of cystic hygroma colli using OK-432. A case report.

Department of Perinatology, National Cardiovascular Center, Osaka, Japan.
Fetal Diagnosis and Therapy (Impact Factor: 2.3). 18(6):391-6.
Source: PubMed

ABSTRACT A 36-year-old multiparous woman was referred at 25 weeks of gestation with suspected cystic hygroma. Ultrasonographic examination demonstrated large multiple cysts around the fetal neck. We treated them by injection of OK-432 at 29 and 32 weeks of gestation. The cysts decreased in size after the intrauterine treatment. A female baby was delivered at 38 weeks of gestation. She was healthy, and there was only a small swelling of the skin in the nuchal area at birth. One month later, the slight swelling of the skin had completely disappeared. Intrauterine injection of OK-432 was a safe and effective therapy for fetal cystic hygroma.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Zystische Raumforderungen (zRF) im Kopf-Hals-Bereich (KHB) sind relativ häufig. Ihre komplette operative Entfernung ist v.a. bei ausgedehnten Befunden und Kontakt zu neurovaskulären Strukturen mit verschiedenen Komplikationen verbunden. Eine Alternative zur chirurgischen Resektion stellt in ausgewählten Fällen die Sklerosierung mit OK-432 dar. Die Erfolgsrate bei lymphatischen Malformationen liegt durchschnittlich bei 60%. Nebenwirkungen treten selten auf. Die Therapie ist minimal invasiv, einfach, ambulant und damit kostengünstig, meist ohne Allgemeinanästhesie, durchführbar. Nervenläsionen oder kosmetisch störende Narben sind nicht beschrieben. Wird eine konsekutive Operation erforderlich, ist sie ohne zusätzliche Schwierigkeiten durchführbar. Der Nachteil besteht in wiederholten Injektionen bei ausbleibender Regredienz des Befundes. Selten kann sich ein Abszess bilden, der einer chirurgischen Therapie bedarf. Vor der Sklerotherapie ist zytologisch ein Malignom auszuschließen. Die intrazystische Injektion von OK-432 ist eine effektive Methode zur Behandlung von zRF im KHB. Cystic lesions are frequently occurring diseases of the head and neck region. Complete surgical resection near to neurovascular structures can be accompanied by various complications. In selected cases intralesional injection of OK-432 could constitute an alternative. The average success rate of sclerotherapy of lymphatic malformations is 60%. Side effects are rare. Sclerotherapy is a minimally invasive, simple and cost-effective procedure performed without general anaesthesia at the outpatient clinic. Nerve lesions or troublesome scarring do not occur. In residual cases surgical excision is realisable without any difficulty. Repeated injections of sclerotherapy agents represent a disadvantage. Abscess formation has been observed as a rare complication. A malignant disease has to be excluded by cytological examination before commencing sclerotherapy. The intracystic injection of OK-432 is an effective treatment modality for cystic cervical lesions.
    HNO 01/2008; 56(3):349-360. · 0.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We present a case of a giant lymphatic malformation of the chest and abdominal wall that was diagnosed in the third trimester of pregnancy. It was treated by one stage excision with good functional and cosmetic outcomes.
    Journal of plastic surgery and hand surgery. 12/2011; 45(6):300-2.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cystic hygroma (CH) is a lymphatic malformation occurring different parts of fetal body, typically in the region of the fetal neck and axillary, abdominal wall, mediastinal, inguinal and retroperitoneal areas. CH has been associated with fetal aneuploidy, hydrops fetalis, structural malformations and intrauterine fetal death.A 24-year-old gravida 1, para 1 was admitted to our hospital at 28 weeks of gestation. Ultrasonographic examination determined 28 weeks of gestation, singleton, alive fetus who had a mass derived from the right axillary region which was extending to the anterior and posterior thoracic wall with fluid-filled cavities about 12 cm in size. There was no evidence of intrathorasic or intraabdominal extension of mass. Cordocentesis was performed and karyotype examination was normal 46 XY. The fetal demise was found after the first visit. The patient was delivered vaginally after labor induction with oxytocin infusion. The fetal autopsy confirmed the diagnosis of CH.The fetal CH carries high risk of aneuploidy and fetal malformations. Patients that have been diagnosed with CH in antenatal follow-ups should be assessed in terms of other anomalies. Fetal karyotyping should be done and the patient should be monitored for fetal hydrops. The birth should be planned in a multidisciplinary hospital and as neonatal resuscitation could be needed, pediatricians should be consulted.
    Rare tumors 10/2011; 3(4):e39.